about
Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire d...
Read More
34.68
2.56
(7.97%)
1.1M
XNAS Volume
High volume+gain today
XNAS 08 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Graphite Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..